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Abstract: Integration of magnetic resonance imaging (MRI) and near-infrared spectral tomography (NIRST) has yielded promising diagnostic performance for breast imaging in the past.
This study focused on whether MRI-guided NIRST can quantify hemoglobin concentration using
only continuous wave (CW) measurements. Patients were classified into four breast density
groups based on their MRIs. Optical scattering properties were assigned based on average values
obtained from these density groups, and MRI-guided NIRST images were reconstructed from
calibrated CW data. Total hemoglobin (HbT) contrast between suspected lesions and surrounding
normal tissue was used as an indicator of the malignancy. Results obtained from simulations
and twenty-four patient cases indicate that the diagnostic power when using only CW data to
differentiate malignant from benign abnormalities is similar to that obtained from combined
frequency domain (FD) and CW data. These findings suggest that eliminating FD detection to
reduce the cost and complexity of MRI-guided NIRST is possible.
© 2021 Optica Publishing Group under the terms of the Optica Open Access Publishing Agreement

1.

Introduction

near-infrared spectral tomography (NIRST) has been investigated as an adjuvant breast imaging
modality [1–3]. Compared to the low sensitivity of ultrasound [4] and the risk of exposure to
ionizing radiation of mammograms or digital tomosynthesis [5], it is non-ionizing, fast, relatively
inexpensive, poses little, if any, health hazards, and therefore, can be used repeatedly to image
subjects without safety concerns [6]. When NIRST is used to acquire volumetric measurements
by placing sources and detectors around the breast, measurements in a plane of diameter up to
106 mm have been detected [7]. Studies have demonstrated that NIRST can differentiate benign
from malignant breast abnormalities [8–14], and monitor the pathological response of breast
cancer to neoadjuvant chemotherapy (NAC) [15,16].
NIRST signal measurement techniques for breast imaging have involved 3 types of methods
[17–19]: continuous wave (CW) [20], frequency domain (FD) [21], and time domain (TD)
[22]. CW imaging systems detect light intensity. Accordingly, they are fast, low cost and very
compatible with MRI, but they do not sense signal phase which is associated strongly with tissue
optical scattering. FD imaging systems use light sources which are intensity-modulated at high
temporal frequency (∼ 100 MHz) to illuminate the breast and acquire light amplitude and phase
shift [23]. Aa a result, FD imaging requires several additional system components that are not
only expensive but also more complex relative to its CW counterpart. For example, source light
has to be intensity modulated with frequencies in the 100MHz range to obtain adequate phase
shift, which requires a laser sub-source system to modulate the light intensity accurately with a
set of microwave devices (∼$10K). For signal detection, a microwave demodulation subsystem,
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which involves low-noise high frequency amplifiers and heterodyning detection modules, is
required. Further, since the optical detectors need very high sensitivity and fast time response
sufficient to detect phase changes in very weak (∼pW) optical signals (transmitted through breast
tissue), photomultiplier tubes (PMTs, ∼$1K/channel) are needed relative to photodiodes (for
CW detection, ∼$10/channel). PMTs are not MRI-compatible; therefore, bulky, heavy, long
fiber bundles (e.g., 12 meter-long, 10mm-in diameter, $60 K for 16 channels as in [9]) are the
only solution to transfer diffuse light collected at the breast surface to PMTs located on an
instrumentation cart placed in the MR console room (whereas photodiodes can be put in the MRI
scanner). Space is limited by the MRI breast coil and scanner, itself, to the extent that only about
16 of these large fiber bundles can be used to cover the breast surface. Tumor coverage has been a
key problem with MR-guided NIRST when based on FD data acquisition (our pilot study showed
that ∼30% of exams resulted in low optical data sensitivity to tumor because of inadequate fiber
placement and/or breast coverage [24]). CW MRI-guided NIRST systems can have many more
channels, for example up to 64 CW channels or more per breast, because of their low cost and
compact size. Thus, FD instruments are more complex and costly.
In contrast to CW imaging, chromophores related to absorption and scattering can be estimated
simultaneously with FD imaging [23]. Studies have shown that the quantitative accuracy of
recovered NIRST parameters is improved when using FD techniques compared to CW methods
[25,26]. TD systems apply short laser pulses with temporal spread below a nanosecond, and detect
the broadened spread of the pulse exiting the breast surface. They also estimate breast absorption
and scattering coefficients, but are even more expensive and more difficult to implement in a
clinical setting relative to FD approaches.
Recently, several NIRST studies have combined FD and CW (FD/CW) systems for breast
imaging [18,27], in which scattering amplitude (SA) and scattering power (SP) are first calibrated
and recovered from FD phase data, and the distribution of hemoglobin concentration and blood
oxygen saturation are then reconstructed from FD/CW amplitude data based on calibrated SA
and SP values. Wang et al. demonstrated that quantitative accuracy in reconstructed NIRST
images is improved with FD/CW data relative to FD data alone [19]. Diagnostic sensitivity,
specificity and AUC reach 90%, 100% and 0.94, respectively with tissue optical index (TOI) as
the NIRST biomarker [9]. However, FD/CW systems increase acquisition time and operational
complexity/cost.
Hemoglobin concentration appears to be the fundamental biomarker for breast diagnosis and
NAC monitoring [28–30]. SA and SP have shown inconsistent differentiation of breast tissue
types. Spinelli et al. showed no significant differentiation [31], while Cerussi et al. found
increased SP in cancers [32]. As a result, CW systems may be the best choice for enhancing
breast diagnosis through MRI-guided NIRST, especially if SA and SP of the breast can be
pre-determined from its density. Here, MRI-based assessment of breast density could be used to
guide the choice of SA and SP values, since optical scattering parameters are correlated with
breast density: fatty breast have low scattering power and extremely dense breasts have high
values [33]. Furthermore, MRI data can be incorporated into NIRST to overcome its poor spatial
resolution and ill-posedness without image segmentation [10,11,13].
In this paper, we investigate whether NIRST, when combined with MRI as a simultaneous,
co-registered breast exam, MRI-guided NIRST, can quantify hemoglobin concentration using
only continuous wave (CW) measurements. The approach assigns optical scattering parameters
based on MRI-derived breast density values, and then reconstructs MRI-guided NIRST images
from calibrated CW data. Results from simulations and twenty-four patient cases were analyzed to
estimate the relative diagnostic performance of the new CW MRI-guided NIRST breast imaging
approach. Findings from the study are important because they will determine whether eliminating
FD detection to reduce cost and complexity of MRI-guided NIRST systems is possible.
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Methods
Imaging procedures

A multi-modality MRI-NIRST system developed at Dartmouth College was used to acquire
NIRST data and MRI images simultaneously from the breasts of women with undiagnosed
abnormalities at time of the imaging exam. Technical details about the combined system can be
found in previous publications [9,14,24].
MRI acquisition consisted of standard (T1, T2, DWI) and dynamic contrast enhanced (DCE)
sequences. NIRST volumetric data (from 16-located sources/detectors) were collected at 6
shorter wavelengths (661, 735, 785, 808, 826 and 852 nm) for FD measurements and 3 longer
wavelengths (903, 912 and 948 nm) for CW measurements. Amplitude data from all nine
wavelengths were used to estimate chromophore concentrations related to breast tissue absorbers.
2.2.

Subjects

A MRI/NIRST imaging protocol was approved by the Institutional Review Board (IRB) for the
Committee for the Protection of Human Subjects at Dartmouth College and at Xijing Hospital.
Criteria for patient enrollment were (i) age greater than 18 years, (ii) breast size and epithelial
integrity adequate to allow NIRST data acquisition, (iii) an undiagnosed palpable mass or
confirmed lesion from clinical imaging, (iv) no prior biopsy within the previous 10 days, (v)
ability to provide informed written consent, and (vi) no serious associated psychiatric illnesses
[9]. The original study collected DCE MRI-guided NIRST exam data from 44 women meeting
these inclusion criteria. Due to optical fiber bundle diameter, length and mass, only 16 channels
were available for FD measurements in the MRI bore with the NIRST instrumentation, and
detector coverage of the breast abnormality of interest with optical sensitivity > 2% (which has
been determined to be the minimum threshold for acceptable NIRST image reconstruction [24])
occurred in the 24 patients evaluated here. Patient information is summarized in Table 1.
Based on MRI T1 images, breast density of each participant was assessed by an experienced
breast radiologist and assigned to one of four subgroups: 1 fatty (F), 10 scattered (S), 6
heterogeneously dense (HD), and 7 extremely dense (ED). Body mass index (BMI) was also
assessed, and averaged across breast density categories for the subjects enrolled (see Table 1).
2.3.

Image reconstruction

Figure 1 shows the flowchart for NIRST image reconstruction. First, a 3D finite element (FE)
mesh was generated from MRI T1 images through the open source software NIRFASTSlicer [34].
To minimize systematic errors from variations in laser intensity at different wavelengths, light
coupling efficiency at different fiber positions, and detector sensitivity, measured amplitude data
for each source-detector pair were calibrated with a homogeneous reference data set acquired
immediately prior to a patient exam. In this study, a direct calibration method is developed for
data calibration, instead of the popular slope-dependent calibration approach [35,36]. The direct
calibration algorithm is described as follows: calibrated data (amplitude only), fc , for image
reconstruction was formed from patient measurements, dp , recorded with the imaging instrument
through normalization by
fr
(1)
fc = dp
dr
where dr is measured on a homogeneous reference phantom and fr is the corresponding simulated
data on the FE mesh. This formula corrected for errors in fiber coupling that were presented in
the data acquired from the reference phantom and patient, and fitted all of the data to the model
in a single step.
Average optical scattering parameters (SA and SP) used in experiments described in this paper
are summarized in Table 1. Here, SA and SP were obtained from prior data [9] in which subjects
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Table 1. Clinical Information of Patients and NIRST Scattering Properties Used in the Study.
Patient
ID

Age
(yrs)

BMI
(kg/m2 )

Radiographic
density

Pathology

Average
BMI
(mm−1 )

Scattering
Amplitude
(mm−1 )

Scattering
Power

Reduced
scattering
parameter
(mm−1 ) for
661 nm

c01

61

23.15

F

IDC

23.15

1.07 ± 0.20

0.13 ± 0.04

0.46 ± 0.07

c02

46

24.03

S

IDC

c03

58

26.04

S

IDC

c04

47

29.30

S

after chemo,
no residue

c05

60

22.60

S

IDC

c06

46

21.48

S

after chemo,
residue

25.01 ± 4.06

1.12 ± 0.15

0.22 ± 0.16

0.40 ± 0.25

c07

33

18.96

S

IDC

c08

58

28.58

S

IDC

c09

60

/

S

IDC

c10

64

31.25

S

IDC

c11

38

22.86

S

adenosis

c12

36

19.83

HD

IDC

c13

38

21.48

HD

IDC

c14

46

22.58

HD

IDC

c15

45

24.97

HD

DC

22.48 ± 1.98

1.16 ± 0.20

0.34 ± 0.20

0.25 ± 0.27

c16

49

25.06

HD

IDC

c17

28

19.53

HD

fibroadenoma

c18

36

23.88

HD

intraductal
papilloma

c19

24

20.20

ED

adenosis

c20

27

22.23

ED

fibroadenoma

c21

23

20.20

ED

adenosis

20.41 ± 1.15

1.26 ± 0.30

0.36 ± 0.24

0.26 ± 0.25

c22

30

19.00

ED

fibroadenoma

c23

20

19.61

ED

fibroadenoma

c24

44

21.22

ED

cystic
hyperplasia

were grouped into 4 breast density categories and their scattering parameter values were averaged
to produce the entries in Table 1.
Initial estimates of chromophore concentrations for HbO, Hb, water and lipid for NIRST
reconstruction were found by fitting amplitude data [35,36]. Absorption coefficients were
determined at each wavelength using a hard-prior based reconstruction [37,38] in which the
breast was assumed to be a single optically homogenous region. This method fits the data to the
model iteratively, is independent of source strength, and can be used with a small number of
data points. Initial property estimates were fed into a single-region, multi-wavelength spectral
reconstruction in order to impose spectral constraints during the fitting process which avoids
local minima [19].
After the initial homogeneous property estimates were generated, NIRST images were recovered
by minimizing the difference between calibrated data, fc , and model data, fm , obtained by solving
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Fig. 1. The flowchart of the algorithm tested here.

diffusion equation:
∧

x = min{||fc − fm (x)||22 }
x

(2)

where x contains the chromophore concentrations for HbO, Hb, water and lipids.
MRI DCE images provided anatomical information for NIRST reconstruction. To encode MRI
DCE data, a direct regularization imaging (DRI) method was adopted [10,13,39]. Accordingly,
the minimization in Eq. (2) was augmented to become
∧

x = min{||fc − fm (x)||22 + β||Lx||22 }
x

(3)

where β is a regularization parameter;L is a weighted matrix constructed from DCE MRI and has
the form
⎧
⎪
⎪
1
i=j
⎪
⎪
(︂
)︂
⎨
⎪
|γi −γj | 2
1
Lij = − Mi exp − 2σ 2 θ(dij )
(4)
i ≠ j&dij <σd
g
⎪
⎪
⎪
⎪
⎪ 0
i ≠ j&dij ≥ σd
⎩
where γi and γj are the grayscale values in the DCE images mapped to the ith and jth nodes
in the finite element mesh, respectively; ri and rj are the positions of nodes i and j, σg is the
characteristic grayscale difference
over which to apply regularization, and Mi is a factor chosen
∑︁
for each row, and satisfies Lij = 0. The function, θ(·), is the Heaviside step function operating
i

over the normalized distance, dij , the distance between nodes i and j, which is normalized by the
maximum distance between all nodes. The distance, dij , determines the local weight applied
to the ith node of the finite element mesh. σd is a factor related to the distance of influence of
elements in the weight matrix relative to the position of node i. In this study, σg and σd were set
to be σg = 0.01, and σd = 0.4.
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Based on the Levenberg-Marquardt (LM) procedure, an update to the chromophore concentrations, ∆xk , at kth iteration was obtained from Eq. (3) as
∆xk = (JkT Jk + βk LT L)JkT (fc − fm (xk−1 ))

(5)

where Jk is the Jacobian matrix at the kth iteration, which has the form
⎡
⎢
⎢
⎢
⎢
Jk = ⎢⎢
⎢
⎢
⎢
⎢
⎣

⎤
JHbO,λ1 JHb,λ1 Jwater,λ1 Jlipid,λ1 ⎥
⎥
⎥
JHbO,λ2 JHb,λ2 Jwater,λ2 Jlipid,λ2 ⎥
⎥
..
⎥
⎥
.
⎥
⎥
JHbO,λn JHb,λn Jwater,λn Jlipid,λn ⎥⎦

(6)

Further details on constructing the Jacobian matrix Jc,λn (c = HbO, Hb, water, lipid) at each
wavelength λn (n = 1, 2, . . . , 9) can be found in [34]. βk is the regularization parameter at the kth
iteration, and is set to be βk = 10 ∗ max(diag(JkT Jk )), fm (xk−1 ) is the forward solution using the
estimated parameters xk−1 from the (k − 1)th iteration. The DRI-based NIRST reconstruction
was implemented by modifying NIRFAST [34].
From the recovered chromophore concentrations, total hemoglobin (HbT) contrast (the ratio
of average HbT in the abnormal region to surrounding normal tissue) was calculated and used to
assess differences in malignant and benign abnormalities in subsequent analyses.
2.4.

Numerical simulation

Three-dimensional (3D) simulations were performed on patient-specific breast MRIs to evaluate
the performance of MRI-guided NIRST image reconstruction based on CW amplitude data alone.
Here, MR scans were segmented into 3 different tissue regions (adipose, fibroglandular, and
tumor tissues) in order to assign optical property values for generating synthetic data. Two
simulation studies were generated: Case 1 was taken from an extremely dense breast with a
23 mm × 40 mm × 70 mm malignancy in the lower middle quadrant approximately 3 mm below
the surface; Case 2 originated from a breast with scattered density and a cancer positioned
centrally 8 mm from the skin surface. The lesion size is 35 mm × 46 mm × 74 mm. After
image segmentation, HbT, water, lipids, SA and SP values for tumor, fibroglandular and
adipose tissues were assigned to each region for numerical simulations [9,13,33]. Data were
generated synthetically from 16 co-located source-detector positions placed around the breast.
For each source illumination, measurements were collected at 15 detector locations for 9 different
wavelengths leading to a total of 2160 values (16 sources × 15 detectors × 9 wavelengths) with
5% added random gaussian noise. To compare outcomes from CW data with assigned SA and
SP parameters, NIRST reconstructions were also computed with FD/CW data – amplitude and
phase at six short wavelengths and amplitude at the remaining three longer wavelengths – to
recover HbT, StO2 , water, lipids, as well as SA and SP images, where Jk in Eq. (6) was calculated
according to a previous study [18].
2.5.

Statistical analysis

Statistical analysis was carried out using Matlab 2018b. A student’s t-test was performed to
examine differences between average HbT contrast in malignant and benign breast abnormalities.
Receiver-operating characteristic (ROC) analysis was also performed to estimate sensitivity
and specificity for detection of malignant versus benign breast abnormalities, and to evaluate
differences in the discrimination of malignant versus benign lesions as a function of cut-off value
across the parameter space. Significance for all statistical tests was assumed at a confidence
interval of 95% (P<0.05) for a two-tailed distribution. We identified the best cutoff point
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corresponding to the largest summation of the average sensitivity and specificity in the ROC
curve.
3.
3.1.

Results
Simulation data

Figure 2(a) and 2(b) show data from MRI T1 and DCE images for simulation Case 1. Typical
HbT, water, lipids, SA and SP values for tumor, adipose and fibroglandular tissues (see Table 2)
were assigned to each region [9,13,33]. True HbT images appear in Fig. 2(c). Values of SA and
SP used in CW reconstruction were selected from the extremely dense group in Table 1. Average
SA and SP values estimated from FD/CW data in tumor were 1.19 and 0.84, while those used
in CW data reconstruction were 1.26 and 0.36, respectively. Figure 2(d) and 2(e) show images
recovered from FD/CW and CW data, respectively. Quantitative comparisons of the estimated
HbT, and the error in HbT (relative to true values) are also reported in Table 2. As shown in
Fig. 2(d) and (e) and Table 2, errors in HbT values recovered with FD/CW data ranged from
9.2% to 76.9% relative to their true values; while they were 4.3% to 79.3% when only CW data
were used. HbT contrast between tumor and surrounding normal tissue was higher with CW data
alone (about 1.8) relative to FD/CW data (about 1.5).

Fig. 2. Images from simulation Case 1: extremely dense breast. (a) MRI T1; (b) MRI DCE;
(c) Ground truth NIRST image overlays; (d) HbT images reconstructed from FD/CW data;
(e) Same as (d) with CW data only. NIRST images are overlaid on the T1 MRI cross-section.
The blue lines denote tumor locations in (b).

MRI T1 and DCE images from simulation Case 2 are shown in Fig. 3(a) and 3(b), respectively.
Reconstructed images with FD/CW and CW data appear in Fig. 3(d) and 3(e), respectively,
and can be compared to ground truth (in Fig. 3(c)). Quantitative reconstruction results are
compiled in Table 3. Similarly to simulation Case 1, errors in recovered HbT values (relative
to true values in each region) varied, but HbT contrast between tumor and surrounding normal
tissue was higher with CW data alone (about 3.6) relative to FD/CW data (2.5) used for image
reconstruction. Results also indicate that when scattering parameters are assigned based on
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Table 2. True and reconstructed NIRST chromophore concentrations in
simulation Case 1.
Tissue region

Method
True

tumor

FD/CW
CW

41.4 ± 8.1

fibroglandular

adipose

Average HbT (µM)

HbT error (%)

SA

SP

39.7

0

1.60

0.6

33.6 ± 3.8

15.4 ± 9.6

1.19

0.84

4.3 ± 20.4

1.26

0.36

True

26.2

0

1.40

0.4

FD/CW

23.8 ± 3.2

9.2 ± 12.2

1.17

0.76

CW

24.8 ± 4.3

5.3 ± 16.4

1.26

0.36

True

12.1

0

1.20

0.30

FD/CW

21.4 ± 2.0

76.9 ± 16.5

1.16

0.73

CW

21.7 ± 2.1

79.3 ± 17.4

1.26

0.36

breast density, recovered HbT contrast between the tumor and the surrounding tissues is higher
with CW data relative to FD/CW data.

Fig. 3. Images from simulation Case 2: scattered breast density. (a) MRI T1; (b) MRI DCE;
(c) Ground truth NIRST image overlays; (d) HbT images reconstructed from FD/CW data;
(e) Same as (d) for CW data only. NIRST images are overlaid on the T1 MRI cross-section.
The blue lines denote tumor locations in (b).

Errors in recovered HbT concentration due to mis-assigned breast density were studied. As
shown in Fig. 4(a), when extremely dense breast density (purple) in the first simulation case
(Fig. 2) was assigned to each of fatty (blue), scattered (red), and heterogeneous dense (green)
breasts, (i.e., underestimating scattering amplitude and power by 15.1% and 61.1%, 11.1% and
38.9%, 7.9% and 5.6%, respectively), errors in recovered HbT concentration in tumor were 51.4%,
37.8% and 20.2%, respectively. The same trend is observed in Fig. 4(b) when scattered breast
density (red) in second simulation case (Fig. 3) was assigned to fatty (blue), homogenous dense
(green), and extremely dense (purple) breasts, (i.e., scattering amplitude and power overestimated
by -4.5% and -36.4%, 3.6% and 54.5%, 12.5% and 63.6%), respectively, errors in recovered HbT
concentration in tumor were 7.3%, 12.6%, and 21.6%, respectively. Also from Fig. 4(b), when
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Table 3. True and reconstructed NIRST chromophore concentrations in
simulation Case 2.
Tissue region

Method
True

tumor

FD/CW
CW

33.4 ± 12.2

fibroglandular

adipose

Average HbT (µM)

HbT error (%)

SA

SP

34.2

0

1.25

0.47

28.0 ± 7.8

18.1 ± 22.8

1.15

0.30

2.3 ± 35.7

1.12

0.22

True

22.4

0

1.05

0.21

FD/CW

13.3 ± 4.7

40.6 ± 21

1.02

0.29

CW

12.3 ± 6.3

45.1 ± 28.1

1.12

0.22

True

12.1

0

0.79

0.10

FD/CW

10.5 ± 2.6

13.2 ± 21.5

1.01

0.29

CW

8.5 ± 3.3

29.8 ± 27.3

1.12

0.22

optical scattering parameters of scattered breast density were assigned to an extremely dense
breast, greater HbT error occurred. We conclude that errors become smaller when the assigned
density was closer to the real density in both simulation cases, indicating that assignment of the
correct breast density based on MRI is important for maintaining diagnostic accuracy when using
only CW data.
Figure 4(c) and (d) show HbT contrast between tumor and surrounding normal tissue. Table 4
reports HbT contrast between tumor and fibroglandular tissues. Figure 4(c) and (d) and Table 4
indicate mis-assigned scattering properties lead to variations in contrast between tumor to
surrounding normal or fibroglandular tissue. Therefore, assigning predetermined scattering
properties according to breast density is important.
Table 4. HbT contrast between tumor and
fibroglandular tissue for simulation
experiments.

3.2.

Experiment

S

F

HD

ED

Simulation case I

1.80

1.81

1.71

1.67

Simulation case II

2.71

2.66

2.70

2.75

Patient data

Patient Case 1: This example illustrates results obtained from a 61-year-old woman with a
20 mm × 27 mm × 33 mm ductal carcinoma in situ and invasive ductal carcinoma in her right
breast. DCE MR images are shown in Fig. 5(b). The breast density was fatty. Her BIRADS
score was 5. Average SA and SP values estimated from FD/CW data for the breast were 1.51 and
0.22, while SA and SP values used in CW data reconstruction were 1.17 and 0.14, respectively.
HbT images reconstructed from FD/CW and CW only data are shown in Fig. 5(c) and 5(d),
respectively. HbT contrasts (shown in Table 5) between tumor and surrounding normal tissue was
1.89, and 3.22 for FD/CW and CW methods, respectively. High values indicate the abnormality
was malignant which was confirmed later by pathology.
Table 5. HbT contrast estimated from images reconstructed with FD/CW or CW
only data.
Experiment

FD/CW data

SA from FD/CW data

SP from FD/CW data

CW data

Patient case 1

1.89

1.51

0.22

3.22

Patient case 2

1.01

1.42

0.49

1.01
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Fig. 4. Recovered HbT concentration in different regions and HbT contrast between the
tumor and surrounding normal tissue when breast density was mis-assigned in simulation
experiments. (a) and (c) The true density is extremely dense in simulation case 1; (b) and (d)
The true density is scattered in simulation case 2.

Patient Case 2: This example presents image data from a 28-year-old woman with a 29
mm × 33 mm × 58 mm fibroadenoma in her right breast. DCE MR images are shown in Fig. 6(b).
The breast density was heterogeneous. Her BIRADS score was 3. Average SA and SP values
estimated from FD/CW data for the breast were 1.42 and 0.49, while those used in CW data
reconstruction were 1.16 and 0.34, respectively. Reconstructed HbT images using FD/CW
and CW only data are illustrated in Fig. 6(c) and 6(d), respectively. No significant contrast
was observed in HbT at the location of presumed tumor (both values were 1.01, see Table 5),
indicating the abnormality was benign which was confirmed later by pathology.
HbT values in surrounding normal breast were about 30 µM in the malignant case (Fig. 5) and
about 21 µM in the benign case (Fig. 6), and fall within inter-subject differences in normal breast
tissue [40]. Average SA and SP values estimated from FD/CW data acquired in these two patient
cases are compiled in Table 5. The assigned SA and SP are more than 18% and 30% lower than
these quantities.
3.3.

Statistical analysis results

When using only CW data, mean HbT contrast in malignant and benign groups was 1.43 and 1.0
with standard deviations 0.55 and 0.05, respectively. They decreased to 1.34 for malignant and
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Fig. 5. Images from patient Case 1: malignancy in fatty breast density. (a) MRI T1; (b) MRI
DCE; (c) and (d) are HbT images reconstructed from FD/CW and CW data, respectively.
NIRST images are overlaid on the T1 MRI cross-section. The blue lines denote tumor
location in (b).

Fig. 6. Images from patient Case 2: a benign abnormality in heterogeneous breast density.
(a) MRI T1; (b) MRI DCE; (c) and (d) are HbT images reconstructed from FD/CW data and
CW data only, respectively. NIRST images are overlaid on the T1 MRI cross-section. The
blue lines denote tumor location in (b).
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remained near 1.0 for benign cases with standard deviations 0.61 and 0.04, respectively, when
FD/CW data were applied. Figure 7(a) contains boxplots of HbT contrast reconstructed based
on FD/CW or CW only data. Patients were classified into two groups: malignant and benign
findings according to pathological results. Significant differences were found in mean HbT
contrast (P<0.05) between pathologically-confirmed malignant and benign abnormalities, using
either FD/CW or CW data. In CW data case, sensitivity, specificity and diagnostic accuracy
were all the same at 87.5%, which was the same as results obtained when using both FD and CW
data. As shown in Fig. 7(b), area under the curve (AUC) is higher (94% vs 88%) when CW data
was applied relative to FD/CW information. Diagnostic performance for the two data formats
is compared in Table 6. In addition, the diagnostic performance of DCE MRI is included in
Table 6 and Fig. 7. The data in Table 6, indicate specificity of DCE MRI alone can be improved
when MRI-guided NIRST is applied including with only CW measurements. Furthermore, we
compared the difference between MRI-guided CW NIRST and DCE MRI ROC curves using
the method of DeLong et al. [41], and found it was 0.13, which was not statistically significant
(p-value = 0.20).

Fig. 7. Statistical results. (a) Boxplots of HbT contrast in malignant (n=16) and benign (n=8)
groups obtained from the images reconstructed from FD/CW and CW data, respectively; (b)
ROC curves of DCE MRI and HbT contrast estimated from the images reconstructed from
FD/CW and CW data, respectively.

Table 6. Diagnostic Performance for Classifying Breast Lesions Based on Using DCE
MRI or FD/CW or CW Data Only Relative to Known Pathology.

4.

Method

P-value

AUC

Sensitivity

Specificity

Accuracy

DCE MRI

0.011

FD/CW

0.045

CW
DCE MRI + CW

Optimal Cutoff

0.81

100%

62.5%

87.5%

>0

0.88

87.5%

87.5%

87.5%

1.02

0.007

0.94

87.5%

87.5%

87.5%

1.05

<0.001

0.97

87.5%

100%

91.7%

/

Discussion and conclusion

Based on both simulated and actual patient image reconstructions, results from this study indicate
that HbT contrast can be maintained using only CW data when prior information on scattering
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properties derived from averages within breast density groups are applied. More specifically,
little degradation in HbT contrast was observed in patient data – average HbT contrast in 24
patients was 1.26 with only CW data, which was 3.3% higher than the HbT contrast recovered
from FD/CW data. Contrast was variable: 9 patients had more than a 10% decrease whereas the
remaining 15 patients had smaller differences. Breasts that exhibited the larger differences in
HbT contrast mostly fell in the HD and ED breast density categories.
Theoretically, combined FD/CW data provide more information, and therefore, should achieve
higher diagnostic performance than only CW data. However, in a practical imaging session, 12
meter long, 10 mm diameter heavy fiber bundles were used to deliver/collect light signals from
the MR console room to the breast in the MRI coil. Although we calibrated phase errors caused by
the fiber bundles and fiber bundle holders on the breast very carefully, phase measurements were
corrupted by noise arising from optical pathlength changes introduced by the fiber bundle layouts
and angles within the holders relative to the breast surface. In our hands, the tradeoff between
acquiring richer FD data versus the phase noise incurred, especially at low signal amplitudes,
favors CW data which achieved slightly higher (but not statistically different) diagnostic power in
the studies reported in this paper (Fig. 7(b)).
Simulation results were generated when scattering properties were fixed as the average of
scattering parameters for all breast densities. For simulation Case 1, average HbT values in
tumor, fibroglandular, and adipose tissues from CW data were 47.2 ± 9.6 µM, 27.5 ± 4.8 µM, and
24.2 ± 2.4 µM, respectively. HbT contrast between tumor and surrounding normal tissue was
1.88, which is 4.4% higher than that from an extremely dense breast. Thus, HbT errors from
average values for all breast densities are larger than those from an extremely dense breast.
Similar results were found in simulation Case 2. Average HbT values reconstructed in tumor,
fibroglandular, and adipose tissues from CW data were 29.5 ± 10.9 µM, 11.0 ± 5.8 µM, and
7.6 ± 3 µM, respectively, when average scattering parameter values for all breast densities were
used. HbT contrast between tumor and surrounding normal tissue was 3.52. Higher HbT
errors and lower contrast were obtained compared to the results reconstructed when scattering
parameters were assigned according to breast density.
In our previous studies, slope-dependent calibration has been used [35,36], in which the slope
of log of intensity times the source-detector distance determines the absorption coefficient that is
fitted at multiple wavelengths to obtain initial estimates of chromophore concentrations. Figure 8
compares estimated HbT concentrations using the direct calibration applied in this study to
those obtained with slope-dependent calibration [35,36]. Although direct calibration result in
a reduction in mean HbT contrast in malignant and benign cases (from 3.1 & 1.1 with slope
dependent calibration to 1.4 & 1.0 with direct calibration), standard deviations also decreased
from 2.9 & 0.2 to 0.5 & 0.05, respectively. Sensitivity, specificity and diagnostic accuracy
remained at 87.5% independently of calibration method, however, area under the curve (AUC)
was slightly higher with direct calibration (0.94 vs 0.9 with slope-dependent calibration), as
shown in Fig. 8(b). The significant reduction in standard deviation of HbT contrast in the
malignant group, and the slightly higher AUC, suggesting that better stability is obtained by
using direct calibration relative to the slope-dependent calibration used previously.
Although the small sample size of this study may cause some limitations of the statistical
analysis, MRI alone tends to have a higher false positive rate for breast cancer diagnosis. As
shown in Table 6, DCE MRI alone had an AUC of 0.81 with specificity and sensitivity of 62.5%
and 100%, respectively; while DCE MRI-guided CW NIRST alone had an AUC of 0.94 with
specificity and sensitivity of 87.5% and 87.5%, respectively. There is no significant difference
between DCE MRI-guided CW NIRST versus DCE MRI performance in terms of AUC. However,
by adding optical data to MRI, the false positive rate of DCE MRI could be reduced. When
DCE MRI-guided NIRST based on CW data and DCE MRI were both used for diagnostic power
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Fig. 8. Statistical results with different data calibration algorithms. (a) Boxplots of HbT
contrast in malignant (n=16) and benign (n=8) groups obtained from reconstructed images
with direct (Direct) and slope-dependent (Slope) calibration methods, respectively; (b) ROC
curves of DCE MRI and HbT contrast estimated from the images reconstructed from direct
and slope-dependent calibration methods, respectively.

analysis, the specificity and AUC can be improved to 100% and 0.97, while maintaining the
sensitivity of 87.5%.
In conclusion, results from this study show that MRI guided NIRST based on CW data
and scattering properties assigned to average values from breast density categories as prior
information, can differentiate benign and malignant legions with diagnostic power similar to
images reconstructed from full FD/CW data. The value of the CW MR-guided NIRST approach
is its simplicity and low cost relative to acquiring frequency domain phase measurements.
While recovering scattering properties for different tissue types may yield more accurate images,
image reconstruction, in this case, requires segmentation in order to assign different scattering
parameters to different types of tissue. The segmentation step adds processing complexity and
reduces objectivity when combining the image information. Additionally, segmentation can be
time-consuming and requires experience to avoid introduction of bias or error. Thus, a direct
regularization imaging method was utilized in this study to avoid the need to perform specific
tissue-type segmentation.
Moreover, our results reveal that assigning the same scattering parameters to fibroglandular and
adipose tissues yields satisfactory results, and simplifies the computational pipeline significantly.
Segmenting fibroglandular tissue from MRI T1 images would provide an accurate breast density
percentage obtainable through fast and automated algorithms. Future work will evaluate the
effects of using MRI-derived fat-fibroglandular percentages to estimate breast density from which
breast scattering properties are determined on optically differentiating malignant from benign
tumors.
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